Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
A pharmaceutical drug initially used to treat people with type 2 diabetes is helping obese people without diabetes lose weight
Glucagon-like peptide 1 (GLP-1) receptor agonists, despite their clinical strength and surging demand, are hitting a wall of attrition fueled by systemic hurdles and behavioral friction
The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
Common Model Organisms The CJC-1295 + Ipamorelin blend has been studied across multiple species and experimental systems: Humans Phase I/II clinical trials in healthy volunteers (ages 21-61)
US$ 23.55
US$ 23.19
US$ 21.83
US$ 24.01
US$ 28.04
US$ 28.20
